Iraq

KEY RESULTS - TB

 

48,600 cases of TB successfully treated

Source: UNDP

Treatment success rate for TB

Source: World Health Organization

27,300 new smear positive TB cases detected and treated

Source: UNDP

Project Summary

In Iraq, the combination of sectarian violence, internal displacement and influx of refugees from Syria poses a severe threat to tuberculosis control efforts. UNDP has been the Principal Recipient of the Global Fund TB grant since 2008. The TB grant has established an emergency cell phone unit which ensures TB patients can be reached and avoid treatment interruptions that threaten to increase drug resistance. In conflict areas, special arrangements, using alternatives routes and local contacts, have enabled continuous delivery of TB medicines to patients. Despite the ongoing conflict, Iraq has managed to achieve an 88% treatment success rate for all new cases of TB and 20,500 new smear positive TB cases have been detected and treated.

Capacity Development - TB testing

Through UNDP-managed programmes, Iraq provided significant support to the National Reference Laboratory (NRL) for TB. As a result the NRL was accredited for the first time for the proficiency of drug susceptibility testing of mycobacteria tuberculosis in 2011 which was a prerequisite from WHO to start diagnosis and treatment of multi-drug resistant (MDR) and extensively drug resistant (XDR) patients.
   

KEY RESULTS  - CONTINUED

 

Maternal and infant mortality

Source: World Health Organization

Domestic spending on TB prevention

Source: World Health Organization

PORTFOLIO OVERVIEW

 

Disease Component

Tuberculosis

Grant

IRQ-T-UNDP

Phase

Period 2

Amount

                        $30,554,029

Rating

 

Overall Grant Rating 

 

 

  Exceeding expectations

 

  Meeting expectations

 

  Adequate

 

  Inadequate but potential demonstrated

 

  Unacceptable

 

  No rating available